Filing Details
- Accession Number:
- 0001415889-24-027648
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-25 17:13:46
- Reporting Period:
- 2024-11-21
- Accepted Time:
- 2024-11-25 17:13:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1613780 | Dbv Technologies S.a. | DBVT | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760395 | Pharis Mohideen | C/O Dbv Technologies S.a. 107, Avenue De La Republique Chatillon I0 92320 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2024-11-21 | 35,000 | $0.00 | 114,367 | No | 4 | A | Direct | |
| Ordinary Shares | Disposition | 2024-11-21 | 2,350 | $0.54 | 112,017 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Employee Stock Option (right to buy) | Acquisiton | 2024-11-21 | 215,000 | $0.00 | 215,000 | $0.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 215,000 | 2034-11-21 | No | 4 | A | Direct |
Footnotes
- The ordinary shares may be represented by American Depositary Shares, each of which currently represents one ordinary share.
- Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 21, 2025, subject to the Reporting Person continuing to provide service through each such date.
- Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
- This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0546 to EURO 1.00 as of November 21, 2024.
- The option shall vest in four equal annual installments commencing on November 21, 2025, subject to the Reporting Person continuing to provide service through each such date.
Billionaire Hedge Funds
